CASP1 and endometrial carcinoma: Negative or weak expression of caspase-1 was observed in 20% (3/15) of endometrial carcinoma cases, and 80% (12/15) showed moderate -to-strong expression, while all benign endometrial specimens showed negative or weak expression of caspase-1 (n = 6).